# Opus Genetics, Inc.: Form 10-Q for the period ended Sep 30, 2019

- Company: [Opus Genetics, Inc.](/companies/ird.md) (CIK 1228627)
- Form: 10-Q
- Filed: 2019-11-06
- Accepted by EDGAR: Nov 6, 2019, 17:01 ET
- Period: 2019-09-30
- Accession: 0001140361-19-019932
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1228627/000114036119019932/form10q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1228627/000114036119019932/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2019-09-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 9 months, 2019-01-01 to 2019-09-30 | $3.0m | us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax |
| Research and development | 3 months, 2019-07-01 to 2019-09-30 | $1.1m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months, 2019-01-01 to 2019-09-30 | $5.0m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months, 2019-07-01 to 2019-09-30 | −$2.3m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months, 2019-01-01 to 2019-09-30 | −$9.2m | us-gaap:OperatingIncomeLoss |
| Net income | 3 months, 2019-07-01 to 2019-09-30 | −$2.0m | us-gaap:NetIncomeLoss |
| Net income | 9 months, 2019-01-01 to 2019-09-30 | −$6.8m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2019-07-01 to 2019-09-30 | −$0.49 | us-gaap:EarningsPerShareBasicAndDiluted |
| Diluted EPS | 9 months, 2019-01-01 to 2019-09-30 | −$1.72 | us-gaap:EarningsPerShareBasicAndDiluted |
| Operating cash flow | 9 months, 2019-01-01 to 2019-09-30 | −$8.6m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Current assets | at 2019-09-30 | $14.6m | us-gaap:AssetsCurrent |
| Total assets | at 2019-09-30 | $15.0m | us-gaap:Assets |
| Current liabilities | at 2019-09-30 | $3.0m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2019-09-30 | $3.2m | us-gaap:Liabilities |
| Shareholders' equity | at 2019-09-30 | $11.8m | us-gaap:StockholdersEquity |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1228627/000114036119019932/form10q.htm

Filed Nov 6, 2019.
Source: SEC EDGAR, the filing index for accession 0001140361-19-019932. Last ingested by Listed: Nov 12, 2026, 19:22 ET. No prices; not investment advice.
